Cargando…
Engineering Advanced Drug Delivery Systems for Dry Eye: A Review
Dry eye disease (DED) is a widespread and frequently reported multifactorial ocular disease that not only causes ocular discomfort but also damages the cornea and conjunctiva. At present, topical administration is the most common treatment modality for DED. Due to the existence of multiple biologica...
Autores principales: | Wang, Tian-Zuo, Liu, Xin-Xin, Wang, Si-Yu, Liu, Yan, Pan, Xin-Yang, Wang, Jing-Jie, Nan, Kai-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854618/ https://www.ncbi.nlm.nih.gov/pubmed/36671625 http://dx.doi.org/10.3390/bioengineering10010053 |
Ejemplares similares
-
Advances in Dry Eye Disease Examination Techniques
por: Wu, Yaying, et al.
Publicado: (2022) -
New Biodegradable Drug Delivery System for Patients with Dry Eye
por: Park, Beom Chan, et al.
Publicado: (2021) -
Management of Sjogren’s Dry Eye Disease—Advances in Ocular Drug Delivery Offering a New Hope
por: Wu, Kevin Y., et al.
Publicado: (2022) -
IFN-γ Facilitates Corneal Epithelial Cell Pyroptosis Through the JAK2/STAT1 Pathway in Dry Eye
por: Yang, Xue, et al.
Publicado: (2023) -
Research Advances of Engineered Exosomes as Drug Delivery
Carrier
por: Huang, Lianghui, et al.
Publicado: (2023)